Will Icahn use the Biogen gambit on Forest?; Dara shares rocket on fast track designation;

@FierceBiotech: Zogenix plots marketing app as pain drug clears PhIII. More | Follow @FierceBiotech

@JohnCFierce: WSJ article on online "dating service" approach to matching approved drugs to new uses. Piece | Follow @JohnCFierce

@RyanMFierce: Far out. Boston Herald reports budding prospects of a Mass. biotech that has sequenced the cannabis genome Item | Follow @RyanMFierce

@MaureenFierce: Only half of doctors surveyed were aware Brilinta was approved. Most won't switch patients from Plavix. Report #sermosurveys | Follow @MaureenFierce

Bloomberg reports that it appears that Carl Icahn can dust off his old game plan for Biogen Idec as he zeroes in on Forest Labs. Report

> Dara BioSciences says that it has received the FDA's fast track designation for its neuropathic pain drug, sending its shares up 27%. Article

> Paladin Labs says CEO Jonathan Goodman was hospitalized after being injured in a serious accident. Story

Pharma News

@FiercePharma: Crains NY predicts Forest Labs will prevail in today's shareholder vote, but Icahn isn't known for giving up easily. Story | Follow @FiercePharma

> Forest declares victory in Icahn proxy fight. Article

> Indian pharma M&A may soon need official OK. More

> In donut hole, Medicare patients don't switch, they stop. Details

> Witness taped Baxter lawyer's payment offer. Story

> Novartis discount sways NICE toward Tasigna. News

> Analysts: Ranbaxy could sell its Lipitor rights. Report

Manufacturing News

> Emerging economy drug makers face lurking challenge. Report

> Turkeys drive Congress to antibiotic action. News

> FDA aims for quality through regulatory science. Story

> The other dark side of Merck's 13,000 layoffs. More

> Recalls expert: Keep a close eye on regulators. Article

> New cause found in most recent Tylenol recall. Details

Vaccine News

> Carbohydrate key to C.diff vaccine. Details

> Novel antibodies could lead to AIDS vaccine. More

> USAID, IDRI for malaria vax collaboration. Report

> TapImmune, Mayo Clinic announce Ph1 breast cancer vaccine trial. News

> Inviragen, U of Texas lands $3M grant for chikungunya vaccine. Article

And Finally... Sniffer dogs could be used for the early detection of lung cancer, according to new research published in the European Respiratory Journal. Report

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.